相似文献
1
A New Class of Antiretroviral Enabling Innate Immunity by Protecting APOBEC3 from HIV Vif-Dependent Degradation.
Trends Mol Med. 2018 May;24(5):507-520. doi: 10.1016/j.molmed.2018.03.004. Epub 2018 Mar 30.
2
Fab-based inhibitors reveal ubiquitin independent functions for HIV Vif neutralization of APOBEC3 restriction factors.
PLoS Pathog. 2018 Jan 5;14(1):e1006830. doi: 10.1371/journal.ppat.1006830. eCollection 2018 Jan.
3
Small-molecule inhibition of HIV-1 Vif.
Nat Biotechnol. 2008 Oct;26(10):1187-92. doi: 10.1038/nbt.1496. Epub 2008 Sep 21.
4
HIV-1 and HIV-2 Vif interact with human APOBEC3 proteins using completely different determinants.
J Virol. 2014 Sep 1;88(17):9893-908. doi: 10.1128/JVI.01318-14. Epub 2014 Jun 18.
5
Determinants of efficient degradation of APOBEC3 restriction factors by HIV-1 Vif.
J Virol. 2014 Dec;88(24):14380-95. doi: 10.1128/JVI.02484-14. Epub 2014 Oct 1.
6
CBFß and HIV Infection.
Adv Exp Med Biol. 2017;962:415-431. doi: 10.1007/978-981-10-3233-2_25.
7
Enhancing immunity to HIV through APOBEC.
Nat Biotechnol. 2008 Oct;26(10):1089-90. doi: 10.1038/nbt1008-1089.
8
Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.
J Mol Biol. 2014 Mar 20;426(6):1220-45. doi: 10.1016/j.jmb.2013.10.033. Epub 2013 Nov 2.
9
Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif protein.
Viruses. 2012 Nov 14;4(11):3132-61. doi: 10.3390/v4113132.
10
Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
J Virol. 2017 Jan 18;91(3). doi: 10.1128/JVI.02230-16. Print 2017 Feb 1.
引用本文的文献
1
Design of Vif-Derived Peptide Inhibitors with Anti-HIV-1 Activity by Interrupting Vif-CBFβ Interaction.
Viruses. 2024 Mar 22;16(4):490. doi: 10.3390/v16040490.
2
DisoFLAG: accurate prediction of protein intrinsic disorder and its functions using graph-based interaction protein language model.
BMC Biol. 2024 Jan 2;22(1):3. doi: 10.1186/s12915-023-01803-y.
3
The coevolution between APOBEC3 and retrotransposons in primates.
Mob DNA. 2022 Nov 29;13(1):27. doi: 10.1186/s13100-022-00283-1.
4
Dominant Negative Mutants of Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) Disrupt Core-Binding Factor Beta-Vif Interaction.
J Virol. 2022 Sep 14;96(17):e0055522. doi: 10.1128/jvi.00555-22. Epub 2022 Aug 11.
5
Aromatic disulfides as potential inhibitors against interaction between deaminase APOBEC3G and HIV infectivity factor.
Acta Biochim Biophys Sin (Shanghai). 2022 May 25;54(5):725-735. doi: 10.3724/abbs.2022049.
6
Characterization of an A3G-Vif-CRL5-CBFβ Structure Using a Cross-linking Mass Spectrometry Pipeline for Integrative Modeling of Host-Pathogen Complexes.
Mol Cell Proteomics. 2021;20:100132. doi: 10.1016/j.mcpro.2021.100132. Epub 2021 Aug 11.
7
A novel HIV-1 inhibitor that blocks viral replication and rescues APOBEC3s by interrupting vif/CBFβ interaction.
J Biol Chem. 2020 Oct 23;295(43):14592-14605. doi: 10.1074/jbc.RA120.013404. Epub 2020 Aug 19.
8
Modulating protein-protein interaction networks in protein homeostasis.
Curr Opin Chem Biol. 2019 Jun;50:55-65. doi: 10.1016/j.cbpa.2019.02.012. Epub 2019 Mar 23.
9
Restriction Factors: From Intrinsic Viral Restriction to Shaping Cellular Immunity Against HIV-1.
Front Immunol. 2018 Dec 6;9:2876. doi: 10.3389/fimmu.2018.02876. eCollection 2018.
本文引用的文献
1
Deep sequencing of HIV-1 reverse transcripts reveals the multifaceted antiviral functions of APOBEC3G.
Nat Microbiol. 2018 Feb;3(2):220-233. doi: 10.1038/s41564-017-0063-9. Epub 2017 Nov 20.
2
Anti-HIV Activities and Mechanism of 12-O-Tricosanoylphorbol-20-acetate, a Novel Phorbol Ester from Ostodes katharinae.
Molecules. 2017 Sep 8;22(9):1498. doi: 10.3390/molecules22091498.
3
Design, synthesis and biological evaluation of indole derivatives as Vif inhibitors.
Bioorg Med Chem Lett. 2017 Sep 1;27(17):4150-4155. doi: 10.1016/j.bmcl.2017.07.026. Epub 2017 Jul 10.
4
Synthesis, biological evaluation and molecular docking study of N-(2-methoxyphenyl)-6-((4-nitrophenyl)sulfonyl)benzamide derivatives as potent HIV-1 Vif antagonists.
Eur J Med Chem. 2017 Mar 31;129:310-324. doi: 10.1016/j.ejmech.2017.01.010. Epub 2017 Jan 12.
5
Translational regulation of APOBEC3G mRNA by Vif requires its 5'UTR and contributes to restoring HIV-1 infectivity.
Sci Rep. 2016 Dec 20;6:39507. doi: 10.1038/srep39507.
6
Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
J Virol. 2017 Jan 18;91(3). doi: 10.1128/JVI.02230-16. Print 2017 Feb 1.
7
An analog of camptothecin inactive against Topoisomerase I is broadly neutralizing of HIV-1 through inhibition of Vif-dependent APOBEC3G degradation.
Antiviral Res. 2016 Dec;136:51-59. doi: 10.1016/j.antiviral.2016.11.001. Epub 2016 Nov 5.
8
The RNA Binding Specificity of Human APOBEC3 Proteins Resembles That of HIV-1 Nucleocapsid.
PLoS Pathog. 2016 Aug 19;12(8):e1005833. doi: 10.1371/journal.ppat.1005833. eCollection 2016 Aug.
9
The APOBEC Protein Family: United by Structure, Divergent in Function.
Trends Biochem Sci. 2016 Jul;41(7):578-594. doi: 10.1016/j.tibs.2016.05.001. Epub 2016 Jun 6.
10
Identification of the HIV-1 Vif and Human APOBEC3G Protein Interface.
Cell Rep. 2015 Dec 1;13(9):1789-99. doi: 10.1016/j.celrep.2015.10.068. Epub 2015 Nov 25.
Zotero 插件